Navigation and service


Dear Doctor letter (Rote Hand Brief) on Cardioxane® (active substance: dexrazoxane): Secondary neoplasia in children

created: 2010.07.26
updated: 2010.07.26

Important safety information on Cardioxane® (dexrazoxane) and increased risk for secondary neoplasia in children.

risk information - full text (available in German only)


© Copyright by BfArM. All Rights Reserved.